Depression and Psychological Distress as Risk Factors for Stroke and Worse Stroke Recovery: Clinical Implications and Therapeutic Options

Depression and Psychological Distress as Risk Factors for Stroke and Worse Stroke Recovery: Clinical Implications and Therapeutic Options

July 14, 2014 at 10:20 AM 0 comments

*Kerstin Sander,1,2 Dirk Sander2,3 1. Department of Psychosomatic Medicine, Schön Klinik Berchtesgadener Land, Bavaria, Germany 2. Department of Neurology, Technical University of Munich, Munich, Germany 3. Department of Neurology, Benedictus Hospital, Tutzing, Germany *Correspondence to Ksander1@mac.com Disclosure: No potential conflict of interest. Received: 07.02.14 Accepted: 09.05.14 Citation: EMJ Neurol. 2014;1:53-58.Read More

Imaging and Treatment Decisions in Seizures and Epilepsy

Imaging and Treatment Decisions in Seizures and Epilepsy

July 14, 2014 at 10:17 AM 0 comments

*Tim J. von Oertzen Wagner-Jauregg Neuroscience Centre, Linz, Austria *Correspondence to neurologiesekr.wj@gespag.at Disclosure: No potential conflict of interest. Received: 10.03.14 Accepted: 29.04.14 Citation: EMJ Neurol. 2014;1:59-64. Abstract It has been clearly shown that magnetic resonance imaging (MRI) is the preferred modality of structural imaging for both new onset seizures andRead More

A Scarlet Enemy of the Brain – A Practical Approach to Diagnosis and Management of Cerebral Amyloid Angiopathy

A Scarlet Enemy of the Brain – A Practical Approach to Diagnosis and Management of Cerebral Amyloid Angiopathy

July 14, 2014 at 10:15 AM 0 comments

*Sue Yin Lim, Amlyn Evans, Tatiana Mihalova Department of Clinical Neurology, Queen’s Medical Centre, Nottingham, UK *Correspondence to sue_yin23@yahoo.com Disclosure: No potential conflict of interest. Received: 19.03.14 Accepted: 22.04.14 Citation: EMJ Neurol. 2014;1:65-71. Abstract We present two cases of elderly patients admitted with neurological dysfunction due to isolated focal corticalRead More

Encephalopathy Associated With Autoimmune Thyroid Disease

Encephalopathy Associated With Autoimmune Thyroid Disease

July 14, 2014 at 10:13 AM 0 comments

Ali A. Raouf, *Gianluca Tamagno Department of General Internal Medicine, St. Columcille’s Hospital, Loughlinstown, Co. Dublin, Ireland *Correspondence to gianlucatamagno@tiscali.it Disclosure: No potential conflict of interest. Received: 25.03.14 Accepted: 17.05.14 Citation: EMJ Neurol. 2014;1:72-77. Abstract Autoimmune thyroid diseases (ATDs) are immune-endocrine disorders affecting the thyroid gland and, eventually, also aRead More

Current Concepts of Neurodegenerative Diseases

Current Concepts of Neurodegenerative Diseases

July 14, 2014 at 10:11 AM 0 comments

*Gabor G. Kovacs Institute of Neurology, Medical University of Vienna, Vienna, Austria *Correspondence to gabor.kovacs@meduniwien.ac.at Disclosure: No potential conflict of interest. Received: 26.03.14 Accepted: 02.05.14 Citation: EMJ Neurol. 2014;1:78-86. Abstract Neurodegenerative diseases (NDDs) are described as disorders with selective loss of neurons and distinct involvement of functional systems defining clinicalRead More

A Note on Changing Approach to Diagnosis of Alzheimer’s Disease

A Note on Changing Approach to Diagnosis of Alzheimer’s Disease

July 14, 2014 at 10:06 AM 0 comments

*Antonio Tartaglione,1,2 Massimo Del Sette1 1. Department of Neurology, Ospedale S. Andrea, La Spezia, Italy 2. Laboratorio della Memoria, RSA Felicia, La Spezia, Italy *Correspondence to ntntartaglione@gmail.com Disclosure: No potential conflict of interest. Received: 04.03.14 Accepted: 23.04.14 Citation: EMJ Neurol. 2014;1:87-94. Abstract This short review summarises the conclusions of twoRead More

Neuropsychiatric Features of Parkinson’s disease with Cognitive Impairment: An Overview

Neuropsychiatric Features of Parkinson’s disease with Cognitive Impairment: An Overview

July 14, 2014 at 10:03 AM 0 comments

Mehran Javeed,1 *Iracema Leroi2,3 1. Carleton Clinic, Cumbria Partnership NHS Foundation Trust, Carlisle, UK 2. Institute of Brain Behaviour and Mental Health, Manchester Academic Health Sciences Centre, Manchester, UK 3. Manchester Mental Health and Social Care Trust, Manchester, UK *Correspondence to Iracema.Leroi@manchester.ac.uk Disclosure: No potential conflict of interest. Received: 04.04.14Read More

Motor System Plasticity and Compensation in Multiple Sclerosis

Motor System Plasticity and Compensation in Multiple Sclerosis

July 14, 2014 at 9:57 AM 0 comments

*Daniel Zeller Department of Neurology, University of Würzburg, Würzburg, Germany *Correspondence to zeller_d@ukw.de Disclosure: The author declares no competing financial interests. Received: 28.01.14 Accepted: 22.05.14 Citation: EMJ Neurol. 2014;1:103-110. Abstract Multiple sclerosis (MS) affects the central nervous system (CNS) by inflammatory lesions, direct axonal injury, and by a rather diffuseRead More

Oligodendrogenesis after Cerebral Ischaemia and Traumatic Brain Injury

Oligodendrogenesis after Cerebral Ischaemia and Traumatic Brain Injury

October 25, 2013 at 6:55 AM 0 comments

Zheng Gang Zhang,1 Michael Chopp1,2 1. Department of Neurology, Henry Ford Hospital, Detroit, Michigan, USA 2. Department of Physics, Oakland University, Rochester, Michigan, USA Disclosure: This work was supported by National Institutes of Health Grants RO1 NS075156 (ZGZ) and AG037506 (MC). The content is solely the responsibility of the authorsRead More

Mode of delivery in Multiple Sclerosis

Mode of delivery in Multiple Sclerosis

September 19, 2013 at 7:01 AM 0 comments

Emanuele D’Amico, Silvia Messina, Francesco Patti Department G.F. Ingrassia, Section of Neurosciences, Università degli Studi di Catania, Catania, Italy Disclosure: No potential conflict of interest. Received: 16.04.13 Accepted: 19.09.13 Citation: EMJ Neurol. 2013;1:32-37. Abstract Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system, affecting women of childbearingRead More